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Summary
Background: High levels of voluntary childlessness and pregnancy‐related fears
have been reported amongst inflammatory bowel disease (IBD) patients.
Aims: To investigate what factors determine IBD patients’ childbearing decisions;
and to examine psychosocial consequences of IBD on various aspects of patients'
reproductive health.
Methods: Six electronic databases were searched in a pre‐specified and structured
manner.
Results: A total of 41 articles with data on 7122 patients were included. Between
one‐fifth to one‐third of IBD patients had chosen voluntary childlessness. Around
50% of all IBD patients have poor knowledge of pregnancy‐related issues in IBD.
Poor knowledge of pregnancy‐related issues in IBD was associated with voluntary
childlessness. Observational studies have found preconception counselling is associ-
ated with patients choosing parenthood. Pregnancy‐related fears and concerns are
multifaceted, stemming partly from lack of knowledge of pregnancy‐related issues in
IBD. Many female patients are considered at increased risk for pregnancy because
between one‐fifth to one‐third of patients do not use contraception. Research evi-
dence for sexual dysfunction after disease diagnosis and treatment is inconsistent.
There are limited data on patients’ pregnancy, postpartum and parenting experi-
ences. A few shortcomings of the literature are evident; sample sizes were small,
participation rates were low, use of non‐validated questionnaires was common, and
few studies included men and/or ethnic minority groups. The design of intervention
studies is also weak.
Conclusion: This review recommends pre‐conception counselling for all IBD
patients of childbearing age to tackle poor knowledge and allow patients to make
an informed decision on their reproductive health.
The Handling Editor for this article was Professor Jonathan Rhodes, and this uncommis-
sioned review was accepted for publication after full peer‐review.
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1 | INTRODUCTION
Inflammatory bowel disease (IBD) is a chronic disease with a relaps-
ing and remitting course and includes Crohn's disease (CD) and
ulcerative colitis (UC). In the UK, the prevalence of CD is about 145
per 100 0001 and UC is around 240 per 100 000.2 IBD usually
affects patients in their childbearing years and the highest incidence
of IBD is among patients aged 20‐29 years old.3
High levels of voluntary childlessness and having fewer children
have been reported in this population.4–6 A review of non‐surgical
IBD studies found that within CD female patients, there was a 17%‐
44% reduction in fertility compared with controls. This was linked to
voluntary childlessness, with no evidence of biological causes of
infertility.7 A large population‐based study with 9639 women with
IBD and 2 131 864 women without IBD, found women with CD
experienced slightly lower birth rates (45.3 live births per 1000 per-
son‐years), compared to those with UC (47.6 live birth per 1000 per-
son‐years), or women from the general population (49.3 live births
per 1000 person‐years). These rates were further impaired following
active disease or surgery.8
High rates of voluntary childlessness or having fewer children
can only be partially explained by existing research on biomedical
factors. For example, active CD, certain types of surgery and certain
medications for male patients may affect fertility and fecundity, and
patients are advised to conceive in remission.9 Exacerbation of dis-
ease during pregnancy is often linked with adverse pregnancy out-
comes, such as increased risk of preterm delivery and low birth
weight.10 Moreover, women with IBD (regardless of phenotype) are
more likely to experience poor maternal and infant outcomes, such
as severe pre‐eclampsia, low 5 minute Apgar score, and (for CD)
major congenital abnormality in offspring, than women without
IBD.11
Given this evidence of increased risks of pregnancy complica-
tions, it is perhaps unsurprising that IBD patients report high levels
of pregnancy‐related fears and anxieties, which include the fear of
IBD affecting pregnancy, worries regarding medication use, fear of
poor pregnancy outcomes, and fear of disease inheritance.5,6,12,13
Patients also have poor knowledge of pregnancy‐related issues in
IBD.6 Knowledge of pregnancy‐related issues is most commonly
tested by the Crohn's and Colitis Pregnancy Knowledge (CCPKnow)
score which contains sub‐scales on knowledge of inheritance of IBD,
conception and medication in the periconceptual period, medication
during pregnancy and breastfeeding, mode of delivery and congenital
abnormalities in babies to mothers with IBD.6 However, existing
reviews on IBD and pregnancy mostly report biomedical aspects of
IBD on pregnancy, management of pregnancy, and drug safety.9,10
Also, practice guidelines such the European Crohn's and Colitis
Organisation's (ECCO) consensus document on reproduction in IBD9
provide little guidance on psychosocial factors which may need to
be managed during pregnancy. Guidelines on pregnancy in IBD, from
the National Institute for Clinical Excellence (NICE), are also limited
to providing patients with information on the potential effects of
IBD on pregnancy, risks and benefits of treatment on fertility, and
ensuring effective communication across specialties.2,14 Furthermore,
there are no provisions of pre‐conception counselling for patients in
the UK and patients will have to approach their healthcare profes-
sionals for any advice. There is no data on how many patients with
IBD actually receive pre‐conception counselling. Additionally, there is
no systematic literature review on the consequences of psychosocial
effects of IBD on patient's reproductive health (ie, reproduction,
pregnancy, maternity, and birth). Therefore, the aims of this review
are to:
1. investigate what factors may determine IBD patients choosing
parenthood or childlessness; and
2. examine the consequences of psychosocial effects of IBD on
patients'
a contraceptive decision‐making;
b sexual function;
c pregnancy and post‐partum experiences.
2 | METHOD
2.1 | Registration
The review has been registered with PROSPERO—
CRD42017078787.
2.2 | Information sources and searches
Six electronic databases which publish gastroenterology‐related
research (CINAHL, PsycINFO, EMBASE, PubMed, Web of Science,
ScienceDirect) were searched. No time, language, or publication
restrictions were applied. See Table S1 for search strategy.
2.3 | Study selection and eligibility criteria
After removing duplicates using bibliographic software (Refworks),
titles, abstracts, and full‐texts were screened independently for eligi-
bility by two reviewers (SP and SC). Any disagreements were
resolved by discussion and agreement between the two reviewers
was recorded to confirm the validity of the screening process. Bibli-
ographies of all identified eligible studies were searched to identify
other potentially eligible (published and unpublished) studies. We
contacted experts for unpublished research and reviewed conference
abstracts. See Table S1 for eligibility criteria.
2.4 | Data collection process and data items
The Joanna Briggs Institute Reviewers’ Manual 201515 was utilised
to extract data. All members of the team were involved in indepen-
dent data extraction and any discrepancies were resolved by discus-
sion. Data extracted included (a) study characteristics (authors, year
of publication, country of origin, study duration, research aims/
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questions, study population, inclusion, and exclusion criteria); (b)
Methodology (sampling method, recruitment, and details of data col-
lection), analysis procedure, and study type (observational, qualita-
tive, mixed‐methods, or intervention); (c) study outcomes and
outcome measurements; and (d) key findings and main conclusions.
2.5 | Quality assessment and risk of bias
All authors were involved in quality assessment. Different quality
assessment tools,16–18 depending on the study design, were used.
No study was excluded based on quality, but we report and discuss
study quality below. Using the quality assessment tools, study qual-
ity was classified as 3‐high; 2‐moderate; or 1‐poor. See Table S2 for
quality assessment system and Table S2 for study quality scoring.
3 | RESULTS
In total, 3596 records were identified through electronic databases
and 5 records through hand searching and contacting authors of con-
ference abstracts (a total of 20 authors were contacted). After dupli-
cates were removed, 1807 titles were screened and 242 abstracts
were reviewed. Of the 242 abstracts, 79 full text articles were exam-
ined in full and 41 articles were included in the review (see Figure 1
for PRISMA flow chart). Agreement between SP and SC through
screening was high (>90% agreement on titles, abstracts and full text).
3.1 | Study characteristics
The 41 included articles reported data on 7122 patients (Table S2).
The majority of studies (k = 30/41) were cross‐sectional surveys,
three were non‐randomised intervention studies,19–21 of which
one21 used no comparison group and only measured one group
before and after an educational intervention. Four studies used con-
tent analysis and performed interviews and coded responses numeri-
cally converting the data into quantitative.13,22–24 There were two
qualitative studies.25,26 Only one cross‐sectional survey study had a
100% male sample,27 all remaining studies included women (k = 24)
or female and male samples (k = 15). The study locations were
mostly in countries with majority White populations (k = 37/41). A
total of k = 12 studies reported participants’ ethnicity, and of these,
k = 11 reported overwhelming White samples (on average 80% of
the samples were White vs 20% other ethnic groups combined) and
only one included 100% British South Asian patients.26
3.2 | Quality
As can be seen from Table S2, study quality varied. Nineteen studies
were scored as poor, 16 as moderate and only six as high. Reasons
for low scores included small samples size (k = 20, 50% of studies
have sample sizes n ≤ 143) and low response rates (k = 29 studies
report response rates, average 25%). Some studies used retrospec-
tive clinic data,28,29 or included retrospective accounts.30 Twenty
studies used non‐standardised and/or not validated outcome mea-
surements (see Table S2). Knowledge of IBD (Crohn's and Colitis
Knowledge Questionnaire)31 was examined in two studies,32,33 while
the remaining studies (k = 7/16) examined the more specific knowl-
edge of pregnancy‐relating issues to IBD (Crohn's and Colitis Preg-
nancy Knowledge score).34 Studies which assessed sexual function,
particularly after surgery, also predominantly used standardised and
validated measurements (k = 6). For sexual function six studies used
the International Index of Erectile Function (IIEF)35 and the Female
Sexual Function Index (FSFI)36; however, these measures have not
been validated within the IBD population. See Table S2 for full list-
ings of questionnaires and measurements used in the literature.
3.3 | Factors that determine IBD patients choosing
parenthood or childlessness
Around one‐fifth to one‐third of IBD patients choose voluntary
childlessness; observed percentages ranged from 17%6; 19.4%37;
29.7%38 to 38%.39 CD patients (18%‐19%) are more likely to choose
voluntary childless than UC patients (14%).6,39 Births rates are also
significantly lower in CD (1 live births per woman) and UC (1.2 live
births per woman) than the general population in Australia (1.81 live
births per woman).5 Two inter‐related determinants of childbearing
decisions emerged from the research literature: (a) poor knowledge
of pregnancy‐related issues in IBD and this often leads to (b) high
levels of pregnancy‐related fears and anxieties.
3.4 | Knowledge of pregnancy‐related issues in IBD
Around 50% of all IBD patients have poor knowledge of pregnancy‐
related issues in IBD. Specifically, half of all participants sampled
scored between 0 and 7 “poor” on CCPKnow scale21,34,37,40,41
(scores which range from 0 to 7 = poor knowledge; 8 to 10 = ade-
quate knowledge; 11 to 13 = good knowledge; and >14 = very good
knowledge of pregnancy‐related issues in IBD). Selinger et al6
(n = 1324) found knowledge of pregnancy‐related issues in IBD
remained low even amongst participants who had actively sought
support and education through IBD Crohn's and Colitis, UK charity
membership (a national charity which provides support, education
and funding for IBD patients and clinicians/academics), 50.8% of the
sample still scored poor on the CCPKnow scale.40 Poor knowledge
of pregnancy‐related (22.4% and 10% able to correctly answer the
pregnancy knowledge question and 11.2% and 7.9% the male fertil-
ity question on the CCknow questionnaire, respectively) issues in
IBD are prevalent across different countries and healthcare systems
in Republic Korean and Chile.32,37
Higher levels of pregnancy‐related knowledge in IBD were associ-
ated with parenthood whereas, lower levels of knowledge were associ-
ated with childlessness. Higher levels of pregnancy‐related knowledge
in IBD were associated with parenthood and lower levels of knowledge
are associated with childlessness. Selinger et al6 conducted a survey
with 1324 female UK patients of childbearing age recruited via Crohn's
and Colitis UK and using the CCPKnow scale. Poor pregnancy‐specific
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disease‐related knowledge was significantly associated with voluntary
childlessness (P < 0.001).6 Moreover, female patients with poor
CCPKnow scores more likely to be voluntarily childless than women
with adequate or higher CCPKnow scores (59.5% vs 42.7%,
P = 0.008). Every point increase in CCPKnow score corresponded to
8% lower odds ratio of childlessness.41 Other factors associated with
childlessness included older age (35 years vs 28 years; P < 0.001),
being single (34.5% vs 9.3% with children; P < 0.001), older age at
diagnosis (25.6 years vs 21.9 years; P < 0.001) and longer disease
duration (13 years vs 8 years; P < 0.032), however poor pregnancy‐re-
lated knowledge was the strongest predictor of childlessness.6,41
Some 40%‐68% of patients do not discuss family planning with
their healthcare professionals.41,42 Patients who received pre‐
conception counselling from healthcare professionals were less likely
to be voluntarily childless.6,41,43 Multivariate logistic regression anal-
ysis estimated that discussing family planning with a physician corre-
sponded to 56% lower odds of having a poor CCPKnow score and
72% lower odds of voluntary childlessness.41 Specifically, the
adjusted OR (for current age and marital status) is 0.28 (95% CI
0.057‐1.3) for the effect of having discussed family planning with a
healthcare professionals on voluntary childlessness among childless
women.41
Socio‐demographic factors were associated with knowledge.
White ethnicity (β = 0.223, P = 0.01; White CCPKnow mean score
8.6 vs non‐White CCPKnow mean score 6.34), membership of IBD
charity (β = 0.200, P = 0.02; charity member CCPKnow mean score
TABLE 1 Summary of the different types of pregnancy‐related concerns and worries reported in the literature (reported as percentages of
participants reporting these concerns)
Study
Study
population
Study
design
General
concerns
of the
effects of
IBD on
pregnancy/
baby
Effects of
pregnancy
on IBD
Pregnancy &
birth
complications
Inheritance
of IBD Infertility
Medication
effects on
pregnancy/
child
Ability
to look
after
child Breastfeeding
Ellul
et al43
N = 348 Cross‐
sectional
survey
63% 63% 68% 22% 73% 13%
Gawron
et al13
N = 129
(n = 73
desiring
future
pregnancy)
Cohort
design.
Phone
survey
56% 27% 25% 25% 53% 10%
Marri
et al39
N = 169
(n = 37
pregnancy
related
responses)
Cross‐
sectional
survey
76% 73% 70%
Mountfield
et al5
N = 255
(n = 48
pregnancy
related
responses)
Cross‐
sectional
survey
18% 15% 35% 30%
Selinger
et al38
N = 145
(n = 96
nulliparous
women)
Cross‐
sectional
survey
90% 91% 54% 74% 46% 19% 43% 64%
Selinger
et al6
N = 1324
(n = 226
voluntary
childless
women)
Cross‐
sectional
survey
59% 31% 67% 67%
Toomey &
Waldron42
N = 31 Cross‐
sectional
survey
68%
Walldorf
et al44
Study
N = 443
(n = 234
childless
women)
Cross‐
sectional
survey
19% 48% 61% 18% 51% 25%
N = entire study sample; n = sub‐sample who were surveyed on their pregnancy related concerns.
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10.18 vs non‐member CCPKnow mean score 7.62) and diagnosis of
CD (β = 0.223, P < 0.001; CD CCPKnow mean score 9.6 vs UC
CCPKnow mean score 7.2) were significant independent predictors
of better pregnancy‐related knowledge.34 University education
(β = 0.292, P < 0.0001; University education CCPKnow mean score
8 vs secondary school education CCPKnow mean score 6), having
spoken to healthcare professional about pregnancy (β = 0.317,
P < 0.0001; yes CCPKnow mean score 8.75 vs no CCPKnow mean
score 5.82) and younger age at IBD diagnosis (β = 0.274, P < 0.003)
were all significant, independent predictors of higher knowledge.40
Other factors significantly associated with higher knowledge
included working full‐time (CCPKnow score 7.18 vs unemployment
CCPKnow score 6.12), being in a long‐term relationship (CCPKnow
7.60 vs being single CCPKnow score 6.26), CD diagnosis (CCPKnow
score 7.51 vs UC diagnosis CCPKnow score 6.97), and having chil-
dren after IBD diagnosis or planning to have children (CCPKnow
Records identified through 
database searching
(n = 3596)
Sc
re
en
in
g
In
cl
ud
ed
El
ig
ib
ilit
y
Id
en
tif
ica
tio
n Additional records identified 
through other sources
(n = 5)
Records after duplicates removed
(n = 1807) 
Records screened
(n = 242)
Records excluded
(n = 1565)
Full-text articles assessed 
for eligibility
(n = 79)
Full-text articles excluded, with reasons
(n = 38)
• No sexual or reproductive health 
focus of article (n = 6)
• Multiple reporting of data (n = 5)
• Only report pregnancy 
outcomes (n = 4)
• Paper focused on physician’s 
attitudes/experiences and not 
patients (n = 4)
• Paper focused on bio-medicine 
aspects of fertility/pregnancy 
(n = 4)
• Review (4)
• Case study (n = 3)
• Population not exclusively IBD 
(n = 3)
• Examined impact of pregnancy 
on risk of IBD (n = 1)
• Letter (n = 1)
• Only report use of contraception 
and not attitudes/experiences of 
use (n = 1)
• Questionnaire validation study 
(n = 1)
• No description of data collection 
tool (n = 1)
Studies included in 
qualitative synthesis
(n = 41)
F IGURE 1 Prisma flow diagram
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7.71 vs having children prior to IBD diagnosis or being infertile or
planning to remain childless CCPKnow 7.05).
Two studies tested educational interventions designed to
improve knowledge. Mayberry20 developed an information booklet
on pregnancy and asked patients and nurses to review its usefulness.
Participants (patients and nurses), overwhelmingly found the infor-
mation booklet helpful (87%) and 71 out of the 102 participants
were prepared to buy the booklet, indicating the need for preg-
nancy‐related information. Mountfield et al21 provided a one‐off
group education session to 155 patients and measured their knowl-
edge before and after the session using the CCPKnow scale. Knowl-
edge was low at baseline (65.1% scored “poor”) and increased
significantly post‐education (P < 0.0001). Importantly, knowledge
regarding medication during pregnancy improved: 33.5% of the par-
ticipants initially thought they should avoid all medication during
pregnancy, but after the education session, this dropped to 1.2%
(P < 0.0001) indicating attempts to improve knowledge can be suc-
cessful.
3.5 | Pregnancy‐related fears and concerns
Pregnancy‐related fears and concerns are multifaceted and stem
from lack of knowledge and awareness. Unlike for knowledge, there
are no validated or standardised measures of pregnancy‐related fears
and concerns. Within the research literature, there is limited evi-
dence of factors associated with pregnancy and disease related con-
cerns or the exact nature of these concerns. Selinger et al38 argued
that poor disease‐related knowledge predicts fears that are inconsis-
tent with medical evidence. One study found nearly 53% of IBD
patients reported that disease‐related concerns affected their deci-
sion‐making regarding pregnancy, with CD patients were significantly
more likely to report disease‐related concerns (62%) than those with
UC (38%) (P = 0.01).13 Additionally, 14% of childless patients
reported their decision not to have children was a direct result of
IBD.5 In one study with amongst exclusively male IBD participants
nearly two‐thirds desired to become fathers (68.4% out of 154), but
still 24% of these reported experiencing some hesitation regarding
having children due to IBD, but the researchers did not further
investigate the exact nature of the hesitations.27 Further, some of
these studies relied on retrospective reports and there was a lack of
prospective evidence regarding the predictive effect of these high
levels of pregnancy‐related concerns on childbearing decisions.
The most common pregnancy‐related fears and concerns
reported by patients are presented in Table 1. Studies have found
that patients often report several pregnancy‐related concerns simul-
taneously, with concerns regarding general concerns over the effects
of pregnancy on IBD (percentages of patients reporting this ranged
from 21%‐79%—see Table 1) and IBD on pregnancy (63%‐90%).
Nearly all of 96 nulliparous female patients from Australia worried
about the general effect of IBD on pregnancy (90%) and about the
effects of pregnancy on IBD (91%), but the specific nature of these
concerns were not noted.38 In a survey of 348 female patients from
six Mediterranean countries [Malta, Greece, Israel, Italy, Portugal,
and Spain] the reasons for voluntary childlessness included fear that
IBD could cause harm to the baby (63%).43 Furthermore, 59% of
226 voluntary childless women reported concerns about the effect
of pregnancy on IBD,6 with specific concerns over the effect of
pregnancy on disease activity,13 or that pregnancy may worsen their
disease (76% of 37).39
Specific concerns regarding the effects of IBD on pregnancy
were noted with concerns regarding birth and pregnancy complica-
tions which ranged from 18% to 63%.6,13,43,44 For example, 63%
feared IBD would lead to a complicated pregnancy.43 In a survey of
443 German IBD women, 234 were childless, and of those 61%
were concerned with risk of miscarriage, and 44.6% of women aged
18‐25 years wanted more information on pregnancy.44 Other con-
cerns included worry that IBD may cause infertility or difficulties
conceiving,13,38,44 and concerns over breastfeeding while on medica-
tion.38
Many patients were also concerned about passing on IBD to
their offspring.5 The percentage of women reporting this concerns
ranged from moderate to high‐59%44; 67%,6 68%43; 74%38; and
73%.39 However, it is unknown whether patients are more likely to
fear transmitting IBD to their offspring in families where IBD is
prevalent, as many studies have not collected this data. Over a third
of all patients reported concerns over the effects of IBD medication
on children during pregnancy.5,13,38,42–44 A survey of 31 IBD patients
found high levels of misconceptions and worries about the effect of
medication during pregnancy42; 68% reported anxiety about the
effect their IBD drugs could have on a pregnancy, a third believed
all drugs should be ceased during pregnancy, 19% said they would
stop their medications even if advised to continue them and 35%
believed an IBD flare‐up is less harmful than continuing medication.
Patients reported concerns about raising a child ranged from
10% to 70%.6,38,39,43 Around 70% of 37 voluntary childless
patients39 and 13% of 348 female patients43 reported concern they
might be unable to care for a child. Whereas, 152 out of 226 volun-
tary childless women had concerns about their ability to cope with
raising a child6 and some nulliparous (42.9% of n = 96) women
reported specific concerns that their disease would negatively impact
on their ability to look after their child.38
3.6 | Psychosocial effects of IBD on reproductive
health
The effect of IBD on patients’ reproductive health is a complex
interaction of biological, psychological, and socio‐cultural factors. The
research literature has mainly examined contraceptive use and sexual
functioning. Research on pregnancy and post‐pregnancy experiences
and attitudes is very limited and there is considerable variability in
study aims. A summary is presented in Data S1
3.7 | Contraceptive use
Although high levels of voluntary childlessness have been reported
in IBD populations, paradoxically, a number of studies using non‐
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validated measurements have found significant numbers of female
patients may also be considered at ‘high‐risk’ for pregnancy. Ellul et
al43 found that more than half of all pregnancies (57.4%) were
unplanned. Between one‐fifth to one‐third of female patients did not
use any contraception (percentage ranged from 18%,39 23%,45 and
31.8%13,22), with the definitions of contraception being reasonably
consistent between the studies. Ellul et al43 found that only 27% of
348 patients used contraceptive methods and that patients who had
received counselling from healthcare professionals regarding the use
of contraception were no more likely to use contraception.
TABLE 2 Recommendations for healthcare professionals based upon the research evidence
General recommendations
Knowledge of pregnancy‐related issues in inflammatory bowel disease (IBD)
Health care professionals should be aware that
 Up to 50% of all IBD patients will have poor knowledge about how their IBD affects fertility and pregnancy.
 Poor knowledge of pregnancy‐related issues in IBD are associated with voluntary childlessness.
 Patients who received pre‐conception counselling from healthcare professionals were less likely to be voluntarily childless.
Health care professionals are recommended to
 Use the validated Crohn's and Colitis Pregnancy Knowledge (CCPKnow) tool34 on childbearing aged patients to screen patients with
poor/adequate knowledge of pregnancy‐related issues in IBD (scores between which range from 0 to 10 on CCPKnow).
 Healthcare professionals should educate patients with poor/adequate knowledge of pregnancy‐related issues on the impact of IBD on
pregnancy and fertility and the impact of pregnancy and breastfeeding on IBD.
 Consider providing patients with educational resources developed by some IBD charities which offers patient‐friendly and evidence‐led
materials to patients (e.g, https://www.crohnsandcolitis.org.uk/).
 Offer patients the opportunity to voice their pregnancy and fertility related concern and respond to these concerns with patient‐specific
advice.
Contraception
Healthcare professionals should be aware that
 Between one‐fifth to one‐third of female patients do not use contraception and patients with a history of IBD‐related surgery or past
biologic therapy use are more likely not to use contraception.
Healthcare professionals are recommended to
 Record the use of contraceptive for all childbearing aged patients in their clinic file.
 Identify patients who are a ‘high’ pregnancy risk.
 Healthcare professionals are advised to provide ‘high’ pregnancy risk patients with appropriate advice on contraception and pre‐
conception counselling to prepare for unplanned pregnancy.
Sexual functioning
Healthcare professionals should be aware that
 For some patients, IBD (particularly during active disease) and surgery has a negative impact on patient's sexual function and satisfaction.
Healthcare professionals are recommended to
 Offer patients the opportunity to discuss sexual function and satisfaction, particularly during active disease or before and after surgery.
 Refer patients identified by the International Index of Erectile Function (IIEF)35 for men and the Female Sexual Function Index (FSFI)36; as
experiencing sexual dysfunction to specialist services such as psychological services, specialists in pelvic floor dysfunction or
gynaecologists, as appropriate and if available.
Medication
Healthcare professionals should be aware that
 A significant number of patients report concerns over the safety of IBD medication during pregnancy and breastfeeding.
 Some studies have reported that around one‐fifth of patients stop taking their medication during pregnancy without medical advice or
believed medication should be stopped.
 The evidence on breastfeeding is mixed and limited.
Health care professionals are recommended to
 Advise patients who are pregnant or postpartum on the effects of medication on pregnancy and breastfeeding.
 Offer patients the opportunity to discuss their concerns regarding medication and respond to patients fears and concerns.
 Healthcare professionals should highlight the importance of patients staying healthy during pregnancy and postpartum period and the
benefits of breastfeeding and the role of medication in this, if appropriate.
 Ask about medication adherence using non‐judgemental, open questions during pregnancy and record medication adherence.
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Participants with a history of IBD‐related surgery (P < 0.03) or
past biologic therapy use (P < 0.05) were less likely to use any con-
traceptive method compared to those without prior surgery or bio-
logic use.45 Education attainment of high school or less was also
associated with no contraceptive use (P < 0.03). Documentation of
contraceptive method was poorly documented at the gastroenterol-
ogy visit, in only 29.2% of cases,29 and only 19% of participants
were provided with reproductive health counselling by their physi-
cians.29
3.8 | Sexual function
A number of studies have investigated the impact of disease and its
treatment on various aspects of patient's sexual lives (particularly
women), investigating mostly sexual function and dysfunction, but
also sexual frequency and occasionally, sexual satisfaction. The rates
of sexual dysfunction in the literature are inconsistent and variable
because of significant heterogeneity in study aims, definition of sex-
ual dysfunction, design and samples between the studies.
Most male and female IBD patients were sexually active, with
30.6% reported weekly and 28.7% reported more frequent than
weekly sexual activity.46 However, sexual frequency was reduced by
IBD (flare‐up) with over half patients (57.6%) reporting this decrease
in frequency, and more females (females 66.3% vs males 40.5%,
P < 0.0001), and participants with history of surgery (68.5% vs
50.4%/non‐operated, P = 0.0113) reporting a decreased frequency of
sexual activity. Without a control group from the general population
it is difficult to judge whether these rates of sexual activity are com-
parable or reduced. More recently a qualitative study, with n = 18
CD and n = 14 UC British South Asian participants, provides some
context to patient's experiences.26 Using semi‐structured interviews,
most of the married participants reported supportive partners but,
some spoke of how having IBD had at times put a strain on their
relationship. This included being too ill to be interested in sex with
one participant reporting “At the beginning when it was… it was all
really bad… I, it was really hard in the bedroom just to be sexually
active, it was so hard… I couldn't make him understand that, you
know, I was having stomach pain, we were arguing constantly
because he'd think I've had something bad to eat”.
Some patients experience sexual dysfunction; but due to con-
flicting results and variability between the studies it is difficult to
establish the percentages of patients reporting sexual dysfunction.
Using a modified but previously validated questionnaire sexual dys-
function amongst 50 women with UC and 100 men with CD/UC
was investigated and compared to a control group.47 Frequency of
patient's sexual intercourse and rates of sexual dyspareunia was
comparable to the control group. However, a number of other stud-
ies have examined the impact of IBD treatments, especially surgery,
on sexual functioning and the findings were inconsistent and contra-
dictory. For example, immunomodulator or biologic agent therapy
has not been found to impact on female or male sexual functioning
using FSFI or IIEF.48 Studies looking at the effect of surgery have
largely focused on colectomy and pouch surgery, where potential
disturbances to the function of the pelvic floor are greatest. In con-
trast, there is a lack of data on patients without surgery and small
bowel Crohn's disease surgery. Dyspareunia was experienced by a
small number of women (n = 8/15) and disturbed erection and or
ejaculation was experienced by 15 (out of 71) male ileostomists who
had undergone colectomies.23 However, this study did not use a val-
idated measure of sexual functioning. More recently, Harnoy et al49
assessed sexual dysfunction in n = 43 male and n = 45 female UC
patients after ileal pouch‐anal anastomosis (IPAA) using FSFI or IIEF
and presented notably higher levels of sexual dysfunction after sur-
gery. Half of the female sample met the criteria for sexual dysfunc-
tion (FSFI score 26) and 29% of men were evaluated as suffering
from moderate to severe erectile dysfunction (IIEF‐5 score 21). Fur-
ther, fear of anal leakage interfered in male and female enjoyment of
sexually activity, however between 55% and 80% of respondents
perceived no change or improved sexual function after surgery.50
Reports of sexual dysfunction after surgery were inconsistent
with some reporting deterioration and some reporting improvement.
For example, in a longitudinal study that assessed perceptions of
relationships and sexual parameters in 37 male and female patients
with UC before and after an ileostomy or an IPAA surgery,51 it was
found that quality of life improved significantly after surgery. There
were partial changes in sexual satisfaction (improvement in female
patients but not male patients) and sexual function (improvement in
male patients but not female) suggesting that changes in sexual func-
tion do not necessarily coincide with changes in sexual satisfaction.
These findings are consistent with other studies which have indi-
cated surgery does not have an adverse effect on male and female
sexual functioning,24,52 and quality of life significantly improves 6
and 12 months post‐operatively.53
In childhood or adolescent UC (n = 25) patients undergoing J‐
pouch ileoanal anastomosis, compared to a control group (n = 38),
there was no evidence that surgery was detrimental to participants
sexual function.54 Similarly, no significant differences were seen in a
case‐controlled study, comparing the sexual function of patients with
pouch failure (n = 36) to an age and sex matched‐control group with
no pouch failure (n = 72).55 However, the pouch failure group scored
significantly worse perceptions of body image than the control
group.55
4 | DISCUSSION
The incidence and prevalence of IBD is rising worldwide,3 so the
number of patients who require reproductive healthcare and educa-
tion will increase. This is the first, comprehensive systematic review
on the psychosocial effects of IBD on patients’ reproductive health.
This review provides rich insight into the psychological reproductive
health of IBD patients and should be read alongside existing reviews
on biomedical aspects of IBD on pregnancy and fertility.9,10 First, we
report high levels of voluntary childlessness amongst IBD popula-
tions with around one‐fifth to one‐third of IBD patients reported
voluntary childlessness. 6,37–39 This is consistent with Tavernier et
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al7 review and rates of voluntary childlessness are often lower
among the general population (<10%) in comparison to IBD popula-
tion.56 Knowledge of pregnancy‐related issues in IBD are consis-
tently poor with half of all patients scoring ‘poor’ on knowledge
scales. Higher levels of pregnancy and fertility knowledge are associ-
ated with parenthood and lower levels of pregnancy and fertility
knowledge are associated with voluntary childlessness. Several
observational studies have found preconception counselling is asso-
ciated with patients choosing parenthood6,43 however only a single
observational study illustrated a predictive association between pre-
conception counselling and reduced odds of voluntary childless-
ness.41 Pregnancy‐related fears and concerns are multifaceted and
often stem from lack of knowledge and, higher levels of pregnancy‐
related fears are associated with voluntary childlessness. Second, a
significant number of female patients (between one‐fifth to one‐
third) may be considered at “high‐risk” for pregnancy because of low
use of contraception. Third, the research evidence for sexual dys-
function after disease and treatment is inconsistent, with some stud-
ies noting high levels of sexual dysfunction and other studies noting
comparable levels to the general population or control groups.
Finally, there is limited evidence on patients’ pregnancy, postpartum
and parenting experiences (see Data S1). Some studies have
reported that around one‐fifth of patients stop taking their medica-
tion during pregnancy without medical advice or believed medication
should be stopped.37,43,57 The evidence on breastfeeding is mixed
and limited.43,58 The quality of evidence is varied and there is limited
evidence from intervention, qualitative, and longitudinal studies.
Current guidelines from the ECCO9 and NICE2,14 provide little
guidance for healthcare professionals on psychological factors that
may need addressing in pregnancy and fertility management. Further,
knowledge of pregnancy and fertility issues relating to IBD is low
across the world21,32–34,37,40,41 and international societies such as
ECCO are pivotal in changing these worldwide trends. Research evi-
dence indicates that pre‐conception counselling is effective at
improving knowledge21 and reducing voluntary childlessness.40,41
However, there are no formal provisions of pre‐conception coun-
selling in the UK and patients have to approach their healthcare pro-
fessionals for advice. This could lead to significant variability in
quality of advice due to the lack of guidelines. This review lends sup-
port to pre‐conception counselling for IBD patients to tackle poor
knowledge and allow patients to make an informed decision on their
reproductive health and childbearing decisions. Based upon research
evidence, pre‐conception counselling could be tailored for patients
which include the recommendations made in Table 2.
We observed that 85% of the studies included in this review
have been published in the past decade (since 2008). This suggest
that researchers and practitioners’ interest on IBD patients’ repro-
ductive health is a recent phenomenon and with greater research
evidence a better service should follow.
The quality of evidence varied. For example, the quality of
research evidence on pregnancy and fertility knowledge was strong
because of the use of validated questionnaires (eg, CCPKnow and
CCKnow) and large sample sizes.6 However, the quality of evidence
for research on pregnancy‐related fears and anxieties, contraception
and sexual function was more mixed, with smaller samples and use
of non‐validated questionnaires. For example, most of the studies on
pregnancy‐related fears and anxieties have used non‐validated ques-
tionnaires6,13,43,44 and they offer limited contextual explanation to
nature of the fears and concerns. However, the picture is complex,
despite studies being poor quality (eg,39) their findings are consistent
in indicating high levels of pregnancy‐related fears. Studies which
measured sexual function were more likely to use validated mea-
sures but had select samples, with the post‐surgery population being
extensively researched but not ‘general’ IBD groups or other sub‐
groups (eg, peri‐anal disease). Further, most studies narrowly
focussed on physical aspects of sexual function and ignored other
aspect of patient's sexual lives (eg, quality of sexual relationship) and
often did not include control groups. Most of the sexual function
studies included heterosexual, but not homosexual patients. The
exclusion of homosexual patients is a significant oversight because
some homosexual patients may experience distress over the disease
and treatment on their sexual lives or other aspect of their reproduc-
tive health.
Finally, most of the studies have investigated the impact of IBD
on exclusively female samples or included female and male samples.
There was only one study that solely investigated the impact of IBD
on men's reproductive health.27 So, the findings from this review
overwhelming represent women's experiences of IBD, and data on
men's experiences and knowledge of pregnancy‐related issues is lim-
ited. Moreover, the majority of the samples included in the study are
White and the findings from this review will, no doubt, over‐repre-
sent White participants’ experiences of IBD and may not be general-
isable to different ethnic groups. Response rate was often low, thus
questioning the accuracy in representing general IBD patient popula-
tions. There was also limited evidence from intervention, qualitative
and longitudinal studies. The design of existing intervention studies
are also weak as none of the interventions have used randomised
controlled trials and some have not used appropriate comparison
control groups 20,21 or used unmatched control groups.19
Although a number of shortcomings with the research literature
have been identified, some clear and consistent evidence emerged.
Based upon the research evidence, clinical implications offered from
the review recommend pre‐conception counselling for childbearing
aged IBD patients to provide better psychosocial care during repro-
ductive health management. Further research on patients’ pregnancy,
postpartum and parenting experiences is warranted. Also, the lack of
qualitative, longitudinal and intervention studies needs to be
addressed to ensure more comprehensive evidence and a greater
methodological rigour in the research literature.
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